Latest News in the pharma Industry
Top Stories
Pfizer Signs Licensing Agreement with Puma
8 Oct 2011
Puma Biotechnology will assume sole responsibility for global development and commercialization of neratinib which is being studied for the treatment of cancer.
Read more
Merck Chairman to Retire in December
8 Oct 2011
Merck & Co.'s former CEO, Richard T. Clark, is retiring as chairman effective December 1st.
Read more
Evotec Forms Drug Discovery Collaboration with UCB
8 Oct 2011
Evotec AG has entered into a multi-target drug discovery collaboration with UCB in the field of immunology.
Read more
Takeda Completes Acquisition of Nycomed
5 Oct 2011
Osaka-based Takeda hopes the addition of the Swiss firm will boost Takeda's sales by approximately 30% and move the company to 12th in the pharmaceutical sales table.
Read more
Rexahn Completes Patient Recruitment in Cancer Drug Trial
4 Oct 2011
Rexahn Pharmaceuticals has completed enrollment for a Phase II clinical trial of its experimental cancer drug Archexin.
Read more
Evotec Takes over Full Ownership of JV in India
30 Sep 2011
Evotec has agreed to acquire the remaining 30% of its Joint Venture with DIL Ltd., India for $2.3 million.
Read more
NIBRT Collaborates with GE Healthcare for Novel Analytical Platforms
29 Sep 2011
The collaboration aims to develop new, robust and reproducible biochemical assays for the analysis of the biological activity of therapeutic monoclonal antibodies.
Read more
Japan's Santen to Acquire French Novagali
29 Sep 2011
Japanese drugmaker Santen Pharmaceutical said on Wednesday it has agreed to buy 50.55 percent of French biopharma Novagali.
Read more
Helsinn Healthcare & Riemser Arzneimittel Expand Licensing Agreement
29 Sep 2011
Helsinn Healthcare and Riemser Arzneimittel signed an agreement to grant marketing rights in Germany to Riemser for a next-generation treatment in development for the prevention of chemotherapy-induced nausea and vomiting.
Read more
AmerisourceBergen to Acquire TheraCom for $250M
28 Sep 2011
Pharmaceutical wholesaler AmerisourceBergen has agreed to buy TheraCom, a subsidiary of CVS Caremark, for $250 million.
Read more
Biotie Therapies to Acquire Newron for €45M
28 Sep 2011
Finnish biotech Biotie Therapies will purchase Italian biopharmaceutical firm Newron Pharmaceuticals for €45m.
Read more
Lonza & Mesoblast Ink Manufacturing Pact for Stem Cell Products
28 Sep 2011
Lonza has entered into a strategic alliance with Australia-based Mesoblast for the production of Mesoblast's adult stem cell therapies.
Read more